Every material Form 8-K AptarGroup filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
AptarGroup reported third-quarter 2026 sales up 6% to $1.02 billion, but reported diluted EPS fell to $0.51 from $1.92 after a $61.2 million pre-tax loss tied to deconsolidating its Russian subsidiary. Adjusted EPS was $1.52, down from $1.62 a year earlier, and the company guided fourth-quarter adjusted EPS to $1.39 to $1.47 while raising its quarterly dividend to $0.50 from $0.48.
Reported sales rose 6% to $1.02 billion; core sales rose 5% in the quarter.
Reported diluted EPS was $0.51 versus $1.92 a year earlier; the Russia deconsolidation cost $0.94 per diluted share after tax.
Adjusted EPS was $1.52 versus $1.62 in the prior year period; Q4 2026 adjusted EPS guidance is $1.39 to $1.47.
Board approved a quarterly dividend increase from $0.48 to $0.50, payable December 3, 2026; Q3 buybacks totaled about 234 thousand shares for $30 million.
AptarGroup's Chief Accounting Officer, Aditya Gandhi, resigned effective September 11, 2026, to pursue another opportunity outside the greater Chicago area, and the company said the decision was not related to any disagreement on operations, policies or practices. The Board appointed Daniel Ackerman, a former CAO, as interim Chief Accounting Officer and principal accounting officer until a permanent successor is named.
Aditya J. Gandhi resigns as Vice President, Chief Accounting Officer, effective September 11, 2026
Daniel Ackerman, age 53, appointed Senior Vice President, Interim Chief Accounting Officer, effective September 11, 2026
Ackerman previously served as CAO from August 1, 2024 until June 8, 2026, and has been SVP, Finance for Aptar Pharma since June 2026
Ackerman will report to Vanessa Kanu, Executive Vice President and Chief Financial Officer
AptarGroup expanded its board from ten to eleven directors and appointed Gael Touya as a director effective September 1, 2026. Touya also became President and Chief Executive Officer that day, succeeding Stephan B. Tanda, who retired; the CEO change was previously disclosed in a March 17, 2026 filing. For shareholders, this filing confirms the leadership transition and board addition, with no financial results or guidance included.
Gael Touya appointed director effective September 1, 2026, with term expiring at the 2028 annual meeting.
Board size increased from ten to eleven directors on August 29, 2026.
Touya, formerly President of the Aptar Pharma segment, became CEO on September 1, 2026, succeeding Stephan B. Tanda.
Touya will not receive additional pay for board service; CEO compensation was disclosed in the March 17, 2026 8-K.
AptarGroup reported second quarter 2026 reported sales up 6% to $1.03 billion, the first quarter above $1 billion, but reported diluted EPS fell to $1.36 from $1.67 a year earlier, and adjusted EPS fell to $1.42 from $1.68. The company expects third quarter adjusted EPS of $1.45 to $1.53, and CEO Stephan Tanda will hand over to Gael Touya on September 1, 2026.
Reported sales rose 6% to $1.03 billion; core sales rose 1%.
Reported diluted EPS was $1.36 versus $1.67; adjusted EPS was $1.42 versus $1.68.
Adjusted EBITDA margin was 20.7% versus 22.6% in the prior year quarter.
Q3 2026 adjusted EPS guidance is $1.45 to $1.53; Gael Touya becomes CEO on September 1, 2026.
AptarGroup said it appointed Aditya J. Gandhi as Vice President and Chief Accounting Officer, effective June 8, 2026, succeeding Daniel Ackerman, who has taken another leadership role within the Aptar Finance organization. Gandhi most recently served as chief accounting officer of Sonoco Products Company and will report to CFO Vanessa Kanu. The filing is a routine leadership change in the finance function and includes no financial results or guidance.
Aditya J. Gandhi, age 46, appointed Vice President and Chief Accounting Officer, effective June 8, 2026
Gandhi succeeds Daniel Ackerman, who steps down as chief accounting officer and principal accounting officer on the same date
Gandhi previously served as chief accounting officer of Sonoco Products Company from August 2022 to May 2026
Offer letter includes a one-time sign-on bonus of $105,000 and a one-time equity award with a grant-date fair value of $715,000
AptarGroup reported first-quarter 2026 sales up 11% to $982.9 million, but core sales were flat and reported net income fell 8% to $73 million. Adjusted EPS was $1.19, down from $1.30 a year earlier at comparable exchange rates, and the company guided second-quarter adjusted EPS to $1.32 to $1.40. The filing also names Gael Touya as the next CEO, effective September 1, 2026.
Reported sales rose 11% to $982.9 million; core sales were flat versus the prior year quarter.
Reported EPS fell 4% to $1.12; adjusted EPS fell 8% to $1.19 from $1.30 at comparable exchange rates.
Q2 2026 adjusted EPS guidance is $1.32 to $1.40, versus $1.67 in Q2 2025 per the filing's reconciliation table.
Gael Touya named Aptar's next CEO effective September 1, 2026.
AptarGroup said CEO Stephan Tanda will retire effective September 1, 2026, and its board has appointed Gael Touya, currently president of the Aptar Pharma segment, as successor CEO on that date. Tanda will stay on as strategic advisor and board member through December 31, 2026, to support the transition.
Gael Touya, age 56, has led the Pharma segment since September 2018 and is expected to join the board on the Effective Date
Touya's initial base salary is $1,060,000, with a 2026 target bonus of 120% of salary
Tanda will serve as strategic advisor through December 31, 2026, with a 2026 target short-term incentive of 130% of salary
Chief Financial Officer Vanessa Kanu and President Hedi Tlili each received restricted stock units with a grant date fair value of $1.3 million
AptarGroup reported fourth-quarter 2025 results with sales up 14% to $963 million, but reported net income fell 26% to $74 million and reported diluted EPS fell 24% to $1.13. Adjusted EPS was $1.25 versus $1.62 a year earlier, and the company set first-quarter 2026 adjusted EPS guidance of $1.13 to $1.21 while approving a new $600 million share repurchase authorization.
Q4 reported sales rose 14% to $963 million; core sales rose 5%, with all three segments showing core sales growth
Q4 reported diluted EPS was $1.13 versus $1.49 a year earlier; adjusted EPS was $1.25 versus $1.62
Q1 2026 adjusted EPS guidance is $1.13 to $1.21, assuming a 21.0% to 23.0% effective tax rate
Board approved a new authorization to repurchase up to $600 million of common stock; Q4 repurchases totaled $175 million
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every AptarGroup filing is on SEC EDGAR ↗. 8-K briefs of other companies →